antigen-presenting - Globe Thesis

Keyword [antigen-presenting] Result: 121 - 140 \| Page: 7 of 7
121.	Immunomodulatory signaling by HCV core protein through the complement receptor,gC1qR, on antigen-presenting cells
122.	Factors influencing function: Activation of antigen presenting cells by the cholera toxin B-subunit, and regulation of the cholinergic phenotype in nerve growth factor receptor-positive basal forebrain cholinergic neurons by bone morphogenetic protein 9
123.	Neonatal and adult lung antigen presenting cells: Examining phenotype and functional responses to bovine respiratory syncytial virus infection
124.	Signaling events involved in PorB induced antigen presenting cell activation and CD86 upregulation
125.	The interaction of Mycobacterium tuberculosis with antigen presenting cells
126.	Rabies virus-based HIV-1 vaccine vector: impact of antigen presenting cells and immunostimulatory molecules
127.	Survival and signaling changes in antigen presenting cell subsets after radiation
128.	Post-translational modification of class II epitopes by activated antigen presenting cells
129.	Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on antigen-presenting cells and molecular signaling pathways in dendritic cells
130.	Interactions between antigen presenting cells and CD4+ T cells in the generation of anti-tumor immunity
131.	Paradoxical effects of gallium arsenide on cathepsin L expression by antigen-presenting cells
132.	The dynamic interactions among CD4(+) T helper, antigen- presenting cells and CD8(+) cytotoxic T cells
133.	The effects of gangliosides on human antigen-presenting cells
134.	Engineering Virus-Mimicking Protein Nanoparticles for Cancer Immunotherapy
135.	Small Extracellular Vesicle PD-L1 Inhibits Antigen Presenting Cells And Associates With The Immunotherapy Response In Oral Squamous Cell Carcinoma & Case Report
136.	Study On The Relationship Between The Occurrence Of Triple-negative Breast Cancer And The Expression Control Of Antigen Presenting Machinery (APM) In Uygur And Han Women
137.	Genetic Characteristics And Pathogenic Mechanism Of A Large Cohort Of SAPHO Syndrome Patients
138.	Tumor Combined Immunotherapy Based On Super Virus Composite Nanomaterials
139.	The Preliminary Study Of Immunological Mechanisms For The Induction Of Donor Specific Tolerance By Ethylenecarbodiimide-treated Human Allogeneic Antigen Presenting Cells
140.	The Role Of HLA Restricted Recombinant Overlapping Peptides Of Tuberculosis In The Diagnosis
<<First <Prev Next> Last>> Jump to